6SHEN J, CHUNG S A, KAYUMOV L, et al. Polysomogra- phic and symptomatological analyses of major depressive disorder patients treated with mirtazapine [ J]. Can JPsychiatry ,2006,51 ( 1 ) :27-34.
7SCHMID D A, WIEHNIAK A, UHR M, et al. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, Prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine [ J]. Neuropsychopharmacology, 2006,31 ( 4 ) : 832- 844.
7MAHADEVA S,GOH KL.Epidemiology of functional dyspepsia:a global perpective[J].World J Gastroenterol,2006,12:2661.
8Van OUDENHOVE L,VANDENBERGHE J,GEERAERTS B,et al.Relatonship between anxiety and gastric sensorimotor function in functional dyspepsia[J].Psychosom Med,2007,69:455.
9TALLEY NJ,WEAVER AL,ZINSMEISTER AR.Impact of functional dyspepsia on quality of life[J].Dig Dis Sci,1995,40:584.
10OTAKA M,JIN M,ODASHIMA M,et al.New strategy of therapy for functional dyspepsia using famotidine,mosapride and amitriptyline[J].Aliment Pharmacol Ther,2005,21(Suppl.2):42.
3Hardoy MC,Carta MG. Strategy to Accelerate or Augment the Antide- pressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder [ J ]. Clin Pract Epidemiol Ment Health,2010(6) :1-3.
